The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Antihistamines come in several formulations, including pills, chewable tablets, syrups, nasal sprays, and eye drops. Many antihistamines are available OTC, but some require a prescription.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.